B
Brian N. Bundy
Researcher at University of South Florida
Publications - 81
Citations - 16774
Brian N. Bundy is an academic researcher from University of South Florida. The author has contributed to research in topics: Gynecologic oncology & Carcinoma. The author has an hindex of 42, co-authored 77 publications receiving 15131 citations. Previous affiliations of Brian N. Bundy include University of Kansas Hospital & Roswell Park Cancer Institute.
Papers
More filters
Journal ArticleDOI
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data.
Michael J. Haller,S. Alice Long,J Lori Blanchfield,Desmond A. Schatz,Jay S. Skyler,Jeffrey P. Krischer,Brian N. Bundy,Susan Geyer,Megan V. Warnock,Jessica L. Miller,Mark A. Atkinson,Dorothy J. Becker,Dorothy J. Becker,David A. Baidal,Linda A. DiMeglio,Stephen E. Gitelman,Robin Goland,Peter A. Gottlieb,Kevan C. Herold,Jennifer B. Marks,Antoinette Moran,Henry Rodriguez,William E. Russell,Darrell M. Wilson,Carla J. Greenbaum +24 more
TL;DR: 2-year area under the curve (AUC) C-peptide and HbA1c, prespecified secondary end points, and potential immunologic correlates are reported to determine whether low-dose ATG might prevent or delay the onset of type 1 diabetes.
Journal ArticleDOI
Rituximab Selectively Suppresses Specific Islet Antibodies
Liping Yu,Kevan C. Herold,Heidi Krause-Steinrauf,Paula McGee,Brian N. Bundy,Alberto Pugliese,Jeffrey P. Krischer,George S. Eisenbarth +7 more
TL;DR: A single course of rituximab differentially suppresses IAAs, clearly blocking IAAs for >1 year in insulin-treated patients, and studies in prediabetic non–insulin- treated patients will likely be needed to evaluate the specific effects of rITUXimab on levels of IAAs.
Journal ArticleDOI
Concepts and problems in the evaluation of screening programs
TL;DR: Specific screening problems addressed within this context include the uses of various definitions of age, the age at which screening is effective, and the marginal contribution of a single screening modality.
Journal ArticleDOI
Groin dissection versus groin radiation in carcinoma of the vulva
TL;DR: Radiation of the intact groins as given in this study is significantly inferior to groin dissection in patients with squamous carcinoma of the vulva and N0-1 nodes.
Journal ArticleDOI
Changing the landscape for type 1 diabetes: the first step to prevention
TL;DR: The results from the TN-10 teplizumab prevention trial show that the diagnosis of type 1 diabetes can be delayed by treatment with a FcR non-binding monoclonal antibody to CD3 in people at high risk for disease.